Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes

Lidia Sojo-Vega,Mònica Recasens,Joan Martínez,Alexandre Aguilera,Maria Ayala,Natàlia Admetlla,Paula Pellicer,Cristina Blay,Berta Fabregat,Mariona Esteve-Serra,Lídia Riera,Rebeca Barahona,Gemma Xifra,Eduardo Esteve,Josefina Biarnés,David Pérez,Gemma Gifre,Sílvia Mauri,Elisabet Costa,Marzena Wos,Maria Buxó,Mercè Fernández-Balsells
DOI: https://doi.org/10.1186/s12933-024-02455-0
IF: 8.949
2024-10-19
Cardiovascular Diabetology
Abstract:Cardiovascular disease (CVD), particularly ischemic heart disease, remains the leading cause of death and morbidity in patients with type 1 diabetes. Detecting subclinical atherosclerosis could enhance cardiovascular risk stratification and enable individualised therapies. The aim of this study is to investigate the prevalence and predictors of subclinical atherosclerosis in patients with type 1 diabetes without overt cardiovascular disease (CVD) and to assess its impact on patient survival over a follow-up period of at least 5 years.
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?